ABSTRACT
The development of mature B lymphocytes from multipotent progenitor cells requires the co-ordinated activities of a number of transcriptional regulatory proteins. The transcription factors encoded by the E2A gene are required for the development of committed B-lineage cells and regulate the expression of essential B-lineage genes at multiple stages of differentiation and activation. In this review we discuss the evidence that the E2A gene products function in the regulation of 1) transcription factors required for B-lineage determination, 2) essential proteins involved in pro-B and pre-B-cell development, 3) accessibilty and recombination of the IgH and IgL chain loci, and 4) isotype switching in activated, mature B lymphocytes.
Subject(s)
B-Lymphocytes/immunology , DNA-Binding Proteins , Transcription Factors/physiology , Animals , Basic Helix-Loop-Helix Transcription Factors , Cell Differentiation , Cell Division , Cell Lineage , Gene Rearrangement, B-Lymphocyte, Light Chain , Helix-Loop-Helix Motifs , Immunoglobulin Class Switching , Interleukin-7/physiology , Mice , Models, Biological , Transcription Factors/chemistryABSTRACT
The E2A proteins, E12 and E47, are required for progression through multiple developmental pathways, including early B and T lymphopoiesis. Here, we provide in vitro and in vivo evidence demonstrating that E47 activity regulates double-positive thymocyte maturation. In the absence of E47 activity, positive selection of both major histocompatibility complex (MHC) class I- and class II-restricted T cell receptors (TCRs) is perturbed. Additionally, development of CD8 lineage T cells in an MHC class I-restricted TCR transgenic background is sensitive to the dosage of E47. Mice deficient for E47 display an increase in production of mature CD4 and CD8 lineage T cells. Furthermore, ectopic expression of an E2A inhibitor helix-loop-helix protein, Id3, promotes the in vitro differentiation of an immature T cell line. These results demonstrate that E2A functions as a regulator of thymocyte positive selection.
Subject(s)
DNA-Binding Proteins/metabolism , Lymphocyte Activation , T-Lymphocytes/immunology , Transcription Factors , Animals , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Cell Survival , DNA-Binding Proteins/deficiency , DNA-Binding Proteins/genetics , Flow Cytometry , Gene Dosage , Helix-Loop-Helix Motifs , Lymphoma, T-Cell/immunology , Major Histocompatibility Complex , Mice , Mice, Knockout , Receptors, Antigen, T-Cell, alpha-beta/immunology , TCF Transcription Factors , Transcription Factor 7-Like 1 Protein , Transfection , Tumor Cells, Cultured , beta 2-Microglobulin/deficiency , beta 2-Microglobulin/genetics , beta 2-Microglobulin/physiologyABSTRACT
The basic helix-loop-helix protein, E2A, is required for proper early B lymphopoiesis. Specifically, in E2A-deficient mice, B-cell development is blocked at the progenitor stage prior to the onset of immunoglobulin (Ig) V(D)J recombination. Here, we demonstrate that E2A plays an additional role during peripheral B lymphopoiesis. Upon activation of primary mature B lymphocytes, both E2A protein levels and DNA-binding activity are induced. Furthermore, we show that mature B cells, expressing a dominant-negative E2A antagonist, proliferate normally in response to mitogenic signaling and appropriately express the early and late activation markers CD69, CD44, IgD and B220. However, in the absence of E2A activity, B lymphocytes are blocked in their ability to express secondary Ig isotypes. We demonstrate that the defect lies at the level of DNA rearrangements between the Ig switch regions. These data suggest that E2A is an essential target during B-cell activation and its induction is required to promote Ig class switch recombination.
Subject(s)
B-Lymphocytes/immunology , DNA-Binding Proteins/metabolism , Immunoglobulin Isotypes/genetics , Immunoglobulin Switch Region , Neoplasm Proteins , Animals , Antigens, CD/analysis , Antigens, Differentiation, T-Lymphocyte/analysis , Biomarkers/analysis , Cell Nucleus/physiology , Cells, Cultured , Flow Cytometry , Helix-Loop-Helix Motifs , Hyaluronan Receptors/analysis , Immunoglobulin D/analysis , Inhibitor of Differentiation Proteins , Lectins, C-Type , Lymphocyte Activation , Mice , Mice, Inbred C57BL , Polymerase Chain Reaction , Recombination, Genetic/immunology , Reverse Transcriptase Polymerase Chain Reaction , Spleen/immunology , TCF Transcription Factors , Th1 Cells/immunology , Th2 Cells/immunology , Transcription Factor 7-Like 1 Protein , Transcription Factors/genetics , Transcription Factors/metabolism , Transcription, GeneticABSTRACT
Proteins of the basic helix-loop-helix (bHLH) family are required for a number of different developmental pathways, including neurogenesis, lymphopoiesis, myogenesis, and sex determination. Using a yeast two-hybrid screen, we have identified a new bHLH transcription factor, ABF-1, from a human B-cell cDNA library. Within the bHLH region, ABF-1 shows a remarkable conservation with other HLH proteins, including tal-1, NeuroD, and paraxis. Its expression pattern is restricted to a subset of lymphoid tissues, Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines, and activated human B cells. ABF-1 is capable of binding an E-box element either as a homodimer or as a heterodimer with E2A. Furthermore, a heterodimeric complex containing ABF-1 and E2A can be detected in EBV-immortalized lymphoblastoid cell lines. ABF-1 contains a transcriptional repression domain and is capable of inhibiting the transactivation capability of E47 in mammalian cells. ABF-1 represents the first example of a B-cell-restricted bHLH protein, and its expression pattern suggests that ABF-1 may play a role in regulating antigen-dependent B-cell differentiation.
Subject(s)
B-Lymphocytes/metabolism , DNA-Binding Proteins/metabolism , Helix-Loop-Helix Motifs , Lymphocyte Activation , Transcription Factors/metabolism , Adenovirus E2 Proteins/metabolism , Amino Acid Sequence , Base Sequence , Basic Helix-Loop-Helix Transcription Factors , Cloning, Molecular , DNA/metabolism , DNA-Binding Proteins/chemistry , DNA-Binding Proteins/genetics , Dimerization , Gene Library , HeLa Cells , Humans , Molecular Sequence Data , Repressor Proteins/metabolism , Sequence Alignment , Transcription Factors/chemistry , Transcription Factors/genetics , TransfectionABSTRACT
A novel D-arabinitol (DA) dehydrogenase was identified and purified more than 300-fold from Candida tropicalis. The enzyme is specific for DA and catalyzes the NAD(+)-dependent oxidation at carbon 4 to yield D-ribulose. Purification was accomplished by a combination of protamine sulfate and ammonium sulfate precipitation and dye ligand chromatography on a reactive yellow 86 column. The apparent Km of the enzyme for DA ([NAD+] = 2.2 mM) is 39.8 mM. The apparent Km for NAD+ ([DA] = 384 mM) is 0.12 mM. The pH-optimum for the enzymatic oxidation of DA is approximately 10. Cofactor stereospecificity studies demonstrate that the enzyme catalyzes transfer of the 4(S) hydrogen of NADH with D-ribulose as substrate. The polyol substrate specificity of the present DA dehydrogenase makes the enzyme potentially useful for the development of a simple and specific method for the measurement of DA, a metabolite of pathogenic Candida spp. which has been described as a marker for disseminated candidiasis.
Subject(s)
Candida/enzymology , Sugar Alcohol Dehydrogenases/isolation & purification , Sugar Alcohol Dehydrogenases/metabolism , Cell Fractionation , Chromatography, Affinity , Electrophoresis, Polyacrylamide Gel , Hydrogen-Ion Concentration , Kinetics , Molecular Weight , Stereoisomerism , Substrate Specificity , UltracentrifugationABSTRACT
Previous studies demonstrated that the amino-terminal portions of E2A and E2-2 are crucial for transactivation. Subsequent findings showed that the same amino-terminal region of E2A is involved in two different translocation events contributing to the induction of a pre-B-cell acute lymphoblastic leukemia and a pro-B-cell acute lymphoblastic leukemia. These results led us to focus on the amino-terminal region of E2A to better understand its normal role in transcriptional regulation and its aberrant involvement in the two leukemias. We report here the identification of two conserved boxes in the E2A amino-terminal domain that show extensive homology within the transactivation domains of E12, E47, E2-2, HEB, and daughterless, all members of the same class of helix-loop-helix proteins. Together, both boxes are crucial for transcriptional activation and have the potential to form a new activation motif, that of a loop adjacent to an amphipathic alpha-helix, designated the loop-helix (LH) motif. A minimal region containing the LH motif is sufficient for transcriptional activation. Point mutations in the amphipathic helix of the minimal region reduce its transactivation capabilities dramatically. The same constructs expressed in yeast cells show identical patterns of activation, suggesting that the LH motif and its target proteins are functionally conserved in yeast cells. We propose that the LH motif represents a novel transactivation domain that is distinct from the previously characterized acidic blob, proline-rich, and glutamine-rich activation motifs. In addition, the LH motif is the first activation motif restricted to one class of DNA binding proteins.